Hitidentification in drug discovery is not always straightforward: A virtualscreening against Mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) did not result in a suitable on-target hit, but testing against pathogenic bacteria revealed promising growth inhibition of Gram-negative Escherichia coli of one compound class. Establishing a robust synthetic route made quick investigation